Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis

(2015) Samuel F. Hunter et al.   CNS DRUGS

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

(2015) Maria A Rocca et al.   LANCET NEUROLOGY

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

(2015) E.-W. Radue et al.   NEUROLOGY

Functional clinical outcomes in multiple sclerosis: Current status and future prospects

(2015) Rana Karabudak et al.   Multiple Sclerosis and Related Disorders

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

The Rao’s Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population

(2013) B. Goretti et al.   NEUROLOGICAL SCIENCES

Treatment of cognitive impairment in patients with multiple sclerosis

(2012) Francesco Patti   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Treatment of cognitive impairment in multiple sclerosis: position paper

(2012) Maria Pia Amato et al.   JOURNAL OF NEUROLOGY

Association of MRI metrics and cognitive impairment in radiologically isolated syndromes

(2012) M. P. Amato et al.   NEUROLOGY

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

(2011) DW Langdon et al.   Multiple Sclerosis Journal

Anatomical and functional differences between the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test

(2010) Cristina Forn et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

(2010) M. Filippi et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

(2009) F. Patti et al.   Multiple Sclerosis Journal

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis

(2009) J. Bellmann-Strobl et al.   NEUROLOGY

Cognitive impairment in multiple sclerosis

(2008) Nancy D Chiaravalloti et al.   LANCET NEUROLOGY

Cognitive impairment in multiple sclerosis

(2008) F Patti   Multiple Sclerosis Journal